vinpocetine has been researched along with Alloxan Diabetes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arava, SK; Arora, T; Kaur, T; Kumar, N; Shah, S; Singh, AP; Vishwakarma, VK; Yadav, HN; Yadav, RK; Yadav, S | 1 |
| Li, H; Li, W; Li, X; Liu, B; Lu, Y; Peng, W; Wang, K; Wen, L; Xu, Y; Zhuang, J | 1 |
2 other study(ies) available for vinpocetine and Alloxan Diabetes
| Article | Year |
|---|---|
Effect of vinpocetine alone and in combination with enalapril in experimental model of diabetic cardiomyopathy in rats: possible involvement of PDE-1/TGF-β/ Smad 2/3 signalling pathways.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Enalapril; Fibrosis; Humans; Phosphoric Diester Hydrolases; Rats; Signal Transduction; Transforming Growth Factor beta | 2023 |
Vinpocetine attenuates neointimal hyperplasia in diabetic rat carotid arteries after balloon injury.
Topics: Animals; Apoptosis; Body Weight; Carotid Arteries; Cell Proliferation; Cells, Cultured; Diabetes Mellitus, Experimental; Hyperplasia; Immunohistochemistry; In Situ Nick-End Labeling; Male; Neointima; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Vinca Alkaloids | 2014 |